The Efficacy of Liposomal Bupivacaine in Regional Nerve Blocks for Below Knee Amputations.
Publication/Presentation Date
7-1-2023
Abstract
Postamputation pain is highly prevalent. Opioids are often utilized postoperatively; however, they have significant side effects. Liposomal bupivacaine (LB) was introduced to extend nerve blocks from hours into days. Regional nerve blocks with LB for below knee amputation (BKA) is a novel approach which may reduce opioid use after surgery. A retrospective review was conducted for patients who had received LB nerve blocks compared to none for postoperative pain control in BKAs. Daily average opioid consumption was evaluated from the time in postoperative acute care unit until day of discharge in oral morphine equivalents (OME). 69 patients who underwent below knee amputations were reviewed. The mean average daily OME was lower in the LB group compared to control group(25.0 vs 50.5 OME, respectively;
Volume
89
Issue
7
First Page
3331
Last Page
3333
ISSN
1555-9823
Published In/Presented At
Allsbrook, A. P., Gotsch, A., To, J., Tran, C., & Pellegrino, A. N. (2023). The Efficacy of Liposomal Bupivacaine in Regional Nerve Blocks for Below Knee Amputations. The American surgeon, 89(7), 3331–3333. https://doi.org/10.1177/00031348231157872
Disciplines
Medicine and Health Sciences
PubMedID
36789557
Department(s)
Department of Surgery
Document Type
Article